Skip to main content

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Access & Citations

  • 9047
    Article Accesses
  • 0
    Web of Science
  • 141
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

Online attention

Altmetric score 32
  • 57 tweeters
  • 116 Mendeley

This article is in the 92nd percentile (ranked 26,723rd) of the 361,526 tracked articles of a similar age in all journals and the 92nd percentile (ranked 5th) of the 54 tracked articles of a similar age in Journal for ImmunoTherapy of Cancer

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.